The polarization of immune cells in the tumour environment by TGFβ

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nature reviews. Immunology

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri2808PMID 20616810PMCID PMC3885992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

  2014cited by this paper
• Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

  2010cited by this paper
• TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

  2010cited by this paper
• Transforming growth factor beta (TGF-beta) and inflammation in cancer.

  2010cited by this paper
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

  2010cited by this paper
• Blockade of TGF‐β enhances tumor vaccine efficacy mediated by CD8+ T cells

  2010cited by this paper
• Targeting the transforming growth factor-β signaling pathway in human cancer

  2010cited by this paper
• Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

  2010cited by this paper
• TH17 cells in tumour immunity and immunotherapy

  2010cited by this paper
• Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma

  2010cited by this paper
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010cited by this paper
• FOXP3 expression and overall survival in breast cancer.

  2009cited by this paper
• Roles of TGFβ in metastasis

  2009cited by this paper
• Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

  2009cited by this paper
• Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination.

  2009cited by this paper
• Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells.

  2009cited by this paper
• Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy

  2009cited by this paper
• Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

  2009cited by this paper
• Dendritic Cell Interactions with NK Cells from Different Tissues

  2009cited by this paper
• Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer

  2009cited by this paper
• Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

  2009cited by this paper
• Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11

  2009cited by this paper
• The inflammasomes: guardians of the body.

  2009cited by this paper
• Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.

  2009cited by this paper
• The TGF-beta paradox in human cancer: an update.

  2009cited by this paper
• Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation

  2009cited by this paper
• Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated.

  2009cited by this paper
• Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

  2009cited by this paper
• Protumor vs Antitumor Functions of IL-171

  2009cited by this paper
• The IL-17/IL-23 axis of inflammation in cancer: friend or foe?

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• Type 17 CD8+ T cells display enhanced antitumor immunity.

  2009cited by this paper
• Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T Cells1

  2009cited by this paper
• Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.

  2009cited by this paper
• Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

  2009cited by this paper
• TGF-β modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression

  2009cited by this paper
• Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies

  2009cited by this paper
• Disruption of TGF-β Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity1

  2009cited by this paper
• Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines

  2009cited by this paper
• Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

  2009cited by this paper
• Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types.

  2009cited by this paper
• Alternative activation of macrophages: an immunologic functional perspective.

  2009cited by this paper
• T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

  2009cited by this paper
• Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.

  2009cited by this paper
• Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells

  2009cited by this paper
• Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

  2009cited by this paper
• Tumour‐derived prostaglandin E2 and transforming growth factor‐β synergize to inhibit plasmacytoid dendritic cell‐derived interferon‐α

  2009cited by this paper
• CD69+CD4+CD25− T Cells, a New Subset of Regulatory T Cells, Suppress T Cell Proliferation through Membrane-Bound TGF-β11

  2009cited by this paper
• The contrasting roles of NKT cells in tumor immunity.

  2009cited by this paper
• Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells1

  2009cited by this paper
• Cutting Edge: In Vitro Generated Th17 Cells Maintain Their Cytokine Expression Program in Normal but Not Lymphopenic Hosts1

  2009cited by this paper
• Adoptive immunotherapy of cancer using CD4(+) T cells.

  2009cited by this paper
• Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody

  2009cited by this paper
• Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers

  2008cited by this paper
• TGF-beta: a master of all T cell trades.

  2008cited by this paper
• Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

  2008cited by this paper
• A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity

  2008cited by this paper
• Tumor-specific Th17-polarized cells eradicate large established melanoma.

  2008cited by this paper
• Activation of a TGF-β-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-β Receptor II1

  2008cited by this paper
• Altered inflammatory responses following transforming growth factor-beta neutralization in experimental guinea pig tuberculous pleurisy.

  2008cited by this paper
• Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

  2008cited by this paper
• Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor

  2008cited by this paper
• Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

  2008cited by this paper
• CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells1

  2008cited by this paper
• Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics

  2008cited by this paper
• First human dose escalation study in patients with metastatic malignancies to determine safety and pharmacokinetics of LY2157299, a small molecule inhibitor of the transforming growth factor-beta receptor I kinase

  2008cited by this paper
• TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction

  2008cited by this paper
• Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.

  2008cited by this paper
• Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Macrophage polarization in tumour progression.

  2008cited by this paper
• Up on the tightrope: natural killer cell activation and inhibition

  2008cited by this paper
• Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells1

  2008cited by this paper
• Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

  2008cited by this paper
• CD8+ suppressor T cells resurrected.

  2008cited by this paper
• Emerging concepts in CD8(+) T regulatory cells.

  2008cited by this paper
• Differentiation of human TH-17 cells does require TGF-β!

  2008cited by this paper
• TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells1

  2008cited by this paper
• Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II.

  2008cited by this paper
• Phase I/II study of GC1008: A human anti-transforming growth factor-beta (TGF{beta}) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)

  2008cited by this paper
• TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.

  2008cited by this paper
• LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

  2008cited by this paper
• An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

  2008cited by this paper
• Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells

  2007cited by this paper
• A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.

  2007cited by this paper
• CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

  2007cited by this paper
• Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β

  2007cited by this paper
• Taking dendritic cells into medicine

  2007cited by this paper
• A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.

  2007cited by this paper
• Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment1

  2007cited by this paper
• Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line

  2007cited by this paper
• Inhibition of human neutrophil degranulation by transforming growth factor‐β1

  2007cited by this paper
• A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

  2007cited by this paper
• Immunostimulatory monoclonal antibodies for cancer therapy

  2007cited by this paper
• Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

  2007cited by this paper
• Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.

  2006cited by this paper
• Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

  2006cited by this paper
• Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

  2006cited by this paper

• Stromal reprogramming-primed nanofiber enhances immune activation for melanoma suppression

  2026cites this paper
• Fibroblasts as Immunological Sentinels in Cutaneous Inflammation: A Review

  2026cites this paper
• The interplay between cytokines and immune checkpoints in breast cancer therapy.

  2026cites this paper
• TGF-β in tumor development and progression: mechanisms and therapeutics

  2026cites this paper
• Bidirectional Regulation in the Tumour Microenvironment: The Interaction Between Tumour-Associated Macrophages and T Cells Reshapes the Paradigm of Cancer Immunotherapy.

  2026cites this paper
• A novel signature of palmitoylation for predicting prognosis and therapeutic response of hepatocellular carcinoma

  2026cites this paper
• CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer

  2026cites this paper
• Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner.

  2026cites this paper
• Obesity, type 2 diabetes and cancers of the digestive system.

  2026cites this paper
• Extracellular Vesicle‐Based Antitumor Nanomedicines

  2025cites this paper
• BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target

  2025cites this paper
• PM2.5暴露通过诱导肿瘤相关巨噬细胞M2极化及IL-1α的分泌促进肺腺癌进展的机制研究

  2025cites this paper
• Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications

  2025cites this paper
• 肝疾病中炎症衰老机制研究进展

  2025cites this paper
• Advancing the understanding of the role of apoptosis in lung cancer immunotherapy: Global research trends, key themes, and emerging frontiers

  2025cites this paper
• Targeting tumor-associated neutrophils: A promising strategy in lung cancer immunotherapy

  2025cites this paper
• A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma

  2025cites this paper
• Assessment of Kynurenine Pathway Enzyme Activity in Ocular Diseases: Associations with Cataract, Diabetes, Glaucoma, and Pseudoexfoliation Syndrome

  2025cites this paper
• Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges

  2025cites this paper
• Impact of Transforming Growth Factor-β2 enriched Food for Special Medical Purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients.

  2025cites this paper
• Chimeric antigen receptor–based cell therapy for treating urological tumors

  2025cites this paper
• Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery.

  2025cites this paper
• Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements

  2025cites this paper
• Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

  2025cites this paper
• Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy

  2025cites this paper
• Annexin A1 Is Involved in the Antitumor Effects of 5-Azacytidine in Human Oral Squamous Carcinoma Cells

  2025cites this paper
• Tumor–Immune Cell Crosstalk Drives Immune Cell Reprogramming Towards a Pro-Tumor Proliferative State Involving STAT3 Activation

  2025cites this paper
• Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub

  2025cites this paper
• Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL

  2025cites this paper
• Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles

  2025cites this paper
• Harnessing the Embryo Antitumor Factor NEPN for Broad-Spectrum Cancer Immunotherapy via Dual Modulation of Tumor Progression and Immune Suppression

  2025cites this paper
• Cancer-Associated Fibroblasts as the “Architect” of the Lung Cancer Immune Microenvironment: Multidimensional Roles and Synergistic Regulation with Radiotherapy

  2025cites this paper
• RON Receptor Signaling and the Tumor Microenvironment

  2025cites this paper
• Co-blockade of TGFβ and PD-1 reinvigorates glioblastoma-infiltrating CD8+ T cells that characteristically upregulate TGFβR expression.

  2025cites this paper
• Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer

  2025cites this paper
• Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

  2025cites this paper
• Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling

  2025cites this paper
• Identification of Cancer Associated Fibroblasts Related Genes Signature to Facilitate Improved Prediction of Prognosis and Responses to Therapy in Patients with Pancreatic Cancer

  2025cites this paper
• TGF-β: A silent player regulating CD8 T cell memory.

  2025cites this paper
• Nonbone Metastasis in Prostate Cancer: Characteristics, Tumor Microenvironment, Diagnosis and Treatment

  2025cites this paper
• Biomolecule-functionalized dental implant surfaces: Towards augmenting soft tissue integration

  2025cites this paper
• Modeling Bistable Dynamics Arising from Macrophage-Tumor Interactions in the Tumor Microenvironment

  2025cites this paper
• Adipose-derived stem cell (ADSC) exosomal hepatocyte growth factor (HGF) regulates apoptosis and migration in inflammationinduced fibroblasts via AKT-FAK

  2025cites this paper
• FAP on human NK cells: insights from NK cell activation and crosstalk with cancer-associated fibroblasts.

  2025cites this paper
• Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs

  2025cites this paper
• Tumor expansion and immune regulation in a mathematical model of cancer under variations in tumor cell proliferation rate and innate immune stimulation.

  2025cites this paper
• Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots

  2025cites this paper
• Immunohistochemical Expression of Interleukin-6 and Transforming Growth Factor Beta-1 on Prostatic Lesions

  2025cites this paper
• Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 delivery

  2025cites this paper
• CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review)

  2025cites this paper
• The hypoxic ECM and neutrophils in MIBC immunotherapy resistance.

  2025cites this paper
• Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities

  2025cites this paper
• Metastatic microenvironment of extrahepatic cholangiocarcinoma.

  2025cites this paper
• Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

  2025cites this paper
• CD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects

  2025cites this paper
• TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance

  2025cites this paper
• Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumors

  2025cites this paper
• Lymphatic Endothelial Cells and Organ-Associated Lymphangiogenesis in Tumor Microenvironment

  2025cites this paper
• Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment

  2025cites this paper
• Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis

  2025cites this paper
• How Do Cancer Cells Create Cancer‐Associated Fibroblast Subtypes? Impacts of Extracellular Vesicles on Stromal Diversity

  2025cites this paper
• Melatonin for gastric cancer treatment: where do we stand?

  2024cites this paper
• CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy.

  2024cites this paper
• The role of transforming growth factor β in cervical carcinogenesis.

  2024cites this paper
• Targeted therapies in hepatocellular carcinoma: past, present, and future

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1

  2024cites this paper
• Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment

  2024cites this paper
• Inhibitory immune checkpoints suppress the surveillance of senescent cells promoting their accumulation with aging and in age-related diseases

  2024cites this paper
• Metabolic heterogeneity in tumor microenvironment - A novel landmark for immunotherapy.

  2024cites this paper
• Dual roles of myeloid-derived suppressor cells in various diseases: a review

  2024cites this paper
• Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression.

  2024cites this paper
• Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress

  2024cites this paper
• Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells

  2024cites this paper
• GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process

  2024cites this paper
• Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

  2024cites this paper
• Natural products with anti-tumorigenesis potential targeting macrophage.

  2024cites this paper
• Therapeutic targeting of TGF‐β in lung cancer

  2024cites this paper
• miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39

  2024cites this paper
• Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment

  2024cites this paper
• Targeting tumor-infiltrating tregs for improved antitumor responses

  2024cites this paper
• Tissue fibroblasts are versatile immune regulators: an evaluation of their impact on the aging process.

  2024cites this paper
• Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts

  2024cites this paper
• Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment

  2024cites this paper
• Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter

  2024cites this paper
• Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer

  2024cites this paper
• The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases

  2024cites this paper
• The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis

  2024cites this paper
• Immunosurveillance encounters cancer metabolism

  2024cites this paper
• Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy

  2024cites this paper
• Prostate cancer immunotherapy. State of the art

  2024cites this paper
• The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of CholangioCarcinoma.

  2024cites this paper
• Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing

  2024cites this paper
• Progress of the Study on Type III Collagen in Breast Cancer

  2024cites this paper
• Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential

  2024cites this paper
• Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape

  2024cites this paper
• Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.

  2024cites this paper
• Impact of Doxorubicin and Docetaxel on Immune Checkpoint Expression in Colorectal Cancer: Insights into Chemotherapy Resistance Mechanisms

  2024cites this paper
• The multifaceted role of SMAD4 in immune cell function

  2024cites this paper
• Senescent Macrophages and the Lung Cancer Microenvironment: A New Perspective on Tumor Immune Evasion

  2024cites this paper